1.The Impact of an Antimicrobial Stewardship Program on Days of Therapy in the Pediatric Center:An Interrupted Time-Series Analysis of a 19-Year Study
Kyung-Ran KIM ; Hyo Jung PARK ; Sun-Young BAEK ; Soo-Han CHOI ; Byung-Kee LEE ; SooJin KIM ; Jong Min KIM ; Ji-Man KANG ; Sun-Ja KIM ; Sae Rom CHOI ; Dongsub KIM ; Joon-sik CHOI ; Yoonsun YOON ; Hwanhee PARK ; Doo Ri KIM ; Areum SHIN ; Seonwoo KIM ; Yae-Jean KIM
Journal of Korean Medical Science 2024;39(21):e172-
		                        		
		                        			 Background:
		                        			We aimed to analyze the effects of an antimicrobial stewardship program (ASP) on the proportion of antimicrobial-resistant pathogens in bacteremia, antimicrobial use, and mortality in pediatric patients. 
		                        		
		                        			Methods:
		                        			A retrospective single-center study was performed on pediatric inpatients under 19 years old who received systemic antimicrobial treatment from 2001 to 2019. A pediatric infectious disease attending physician started ASP in January 2008. The study period was divided into the pre-intervention (2001–2008) and the post-intervention (2009–2019) periods. The amount of antimicrobial use was defined as days of therapy per 1,000 patientdays, and the differences were compared using delta slope (= changes in slopes) between the two study periods by an interrupted time-series analysis. The proportion of resistant pathogens and the 30-day overall mortality rate were analyzed by the χ2 . 
		                        		
		                        			Results:
		                        			The proportion of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia increased from 17% (39 of 235) in the pre-intervention period to 35% (189 of 533) in the post-intervention period (P < 0.001). The total amount of antimicrobial use significantly decreased after the introduction of ASP (delta slope value = −16.5; 95% confidence interval [CI], −30.6 to −2.3; P = 0.049). The 30-day overall mortality rate in patients with bacteremia did not increase, being 10% (55 of 564) in the pre-intervention and 10% (94 of 941) in the post-intervention period (P = 0.881). 
		                        		
		                        			Conclusion
		                        			The introduction of ASP for pediatric patients reduced the delta slope of the total antimicrobial use without increasing the mortality rate despite an increased incidence of ESBL-producing gram-negative bacteremia. 
		                        		
		                        		
		                        		
		                        	
2.The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Survey About Specific Clinical Scenarios (Version 2023.1)
Min-Sung KIM ; Se-Il GO ; Chan Woo WEE ; Min Ho LEE ; Seok-Gu KANG ; Kyeong-O GO ; Sae Min KWON ; Woohyun KIM ; Yun-Sik DHO ; Sung-Hye PARK ; Youngbeom SEO ; Sang Woo SONG ; Stephen AHN ; Hyuk-Jin OH ; Hong In YOON ; Sea-Won LEE ; Joo Ho LEE ; Kyung Rae CHO ; Jung Won CHOI ; Je Beom HONG ; Kihwan HWANG ; Chul-Kee PARK ; Do Hoon LIM ;
Brain Tumor Research and Treatment 2023;11(2):133-139
		                        		
		                        			 Background:
		                        			During the coronavirus disease 2019 (COVID-19) pandemic, there was a shortage of medical resources and the need for proper treatment guidelines for brain tumor patients became more pressing. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has undertaken efforts to develop a guideline that is tailored to the domestic situation and that can be used in similar crisis situations in the future. As part II of the guideline, this consensus survey is to suggest management options in specific clinical scenarios during the crisis period. 
		                        		
		                        			Methods:
		                        			The KSNO Guideline Working Group consisted of 22 multidisciplinary experts on neuro-oncology in Korea. In order to confirm a consensus reached by the experts, opinions on 5 specific clinical scenarios about the management of brain tumor patients during the crisis period were devised and asked. To build-up the consensus process, Delphi method was employed. 
		                        		
		                        			Results:
		                        			The summary of the final consensus from each scenario are as follows. For patients with newly diagnosed astrocytoma with isocitrate dehydrogenase (IDH)-mutant and oligodendroglioma with IDH-mutant/1p19q codeleted, observation was preferred for patients with low-risk, World Health Organization (WHO) grade 2, and Karnofsky Performance Scale (KPS) ≥60, while adjuvant radiotherapy alone was preferred for patients with high-risk, WHO grade 2, and KPS ≥60. For newly diagnosed patients with glioblastoma, the most preferred adjuvant treatment strategy after surgery was radiotherapy plus temozolomide except for patients aged ≥70 years with KPS of 60 and unmethylated MGMT promoters. In patients with symptomatic brain metastasis, the preferred treatment differed according to the number of brain metastasis and performance status. For patients with newly diagnosed atypical meningioma, adjuvant radiation was deferred in patients with older age, poor performance status, complete resection, or low mitotic count. 
		                        		
		                        			Conclusion
		                        			It is imperative that proper medical care for brain tumor patients be sustained and provided, even during the crisis period. The findings of this consensus survey will be a useful reference in determining appropriate treatment options for brain tumor patients in the specific clinical scenarios covered by the survey during the future crisis. 
		                        		
		                        		
		                        		
		                        	
3.The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Recommendation Using the Delphi Method (Version 2023.1)
Min-Sung KIM ; Se-Il GO ; Chan Woo WEE ; Min Ho LEE ; Seok-Gu KANG ; Kyeong-O GO ; Sae Min KWON ; Woohyun KIM ; Yun-Sik DHO ; Sung-Hye PARK ; Youngbeom SEO ; Sang Woo SONG ; Stephen AHN ; Hyuk-Jin OH ; Hong In YOON ; Sea-Won LEE ; Joo Ho LEE ; Kyung Rae CHO ; Jung Won CHOI ; Je Beom HONG ; Kihwan HWANG ; Chul-Kee PARK ; Do Hoon LIM ;
Brain Tumor Research and Treatment 2023;11(2):123-132
		                        		
		                        			 Background:
		                        			During the coronavirus disease 2019 (COVID-19) pandemic, the need for appropriate treatment guidelines for patients with brain tumors was indispensable due to the lack and limitations of medical resources. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has undertaken efforts to develop a guideline that is tailored to the domestic situation and that can be used in similar crisis situations in the future. 
		                        		
		                        			Methods:
		                        			The KSNO Guideline Working Group was composed of 22 multidisciplinary experts on neuro-oncology in Korea. In order to reach consensus among the experts, the Delphi method was used to build up the final recommendations. 
		                        		
		                        			Results:
		                        			All participating experts completed the series of surveys, and the results of final survey were used to draft the current consensus recommendations. Priority levels of surgery and radiotherapy during crises were proposed using appropriate time window-based criteria for management outcome. The highest priority for surgery is assigned to patients who are life-threatening or have a risk of significant impact on a patient’s prognosis unless immediate intervention is given within 24–48 hours. As for the radiotherapy, patients who are at risk of compromising their overall survival or neurological status within 4–6 weeks are assigned to the highest priority. Curative-intent chemotherapy has the highest priority, followed by neoadjuvant/adjuvant and palliative chemotherapy during a crisis period. Telemedicine should be actively considered as a management tool for brain tumor patients during the mass infection crises such as the COVID-19 pandemic. 
		                        		
		                        			Conclusion
		                        			It is crucial that adequate medical care for patients with brain tumors is maintained and provided, even during times of crisis. This guideline will serve as a valuable resource, assisting in the delivery of treatment to brain tumor patients in the event of any future crisis. 
		                        		
		                        		
		                        		
		                        	
4.2021 Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations
Eun Ju HA ; Sae Rom CHUNG ; Dong Gyu NA ; Hye Shin AHN ; Jin CHUNG ; Ji Ye LEE ; Jeong Seon PARK ; Roh-Eul YOO ; Jung Hwan BAEK ; Sun Mi BAEK ; Seong Whi CHO ; Yoon Jung CHOI ; Soo Yeon HAHN ; So Lyung JUNG ; Ji-hoon KIM ; Seul Kee KIM ; Soo Jin KIM ; Chang Yoon LEE ; Ho Kyu LEE ; Jeong Hyun LEE ; Young Hen LEE ; Hyun Kyung LIM ; Jung Hee SHIN ; Jung Suk SIM ; Jin Young SUNG ; Jung Hyun YOON ; Miyoung CHOI
Korean Journal of Radiology 2021;22(12):2094-2123
		                        		
		                        			
		                        			 Incidental thyroid nodules are commonly detected on ultrasonography (US). This has contributed to the rapidly rising incidence of low-risk papillary thyroid carcinoma over the last 20 years. The appropriate diagnosis and management of these patients is based on the risk factors related to the patients as well as the thyroid nodules. The Korean Society of Thyroid Radiology (KSThR) published consensus recommendations for US-based management of thyroid nodules in 2011 and revised them in 2016. These guidelines have been used as the standard guidelines in Korea. However, recent advances in the diagnosis and management of thyroid nodules have necessitated the revision of the original recommendations. The task force of the KSThR has revised the Korean Thyroid Imaging Reporting and Data System and recommendations for US lexicon, biopsy criteria, US criteria of extrathyroidal extension, optimal thyroid computed tomography protocol, and US follow-up of thyroid nodules before and after biopsy. The biopsy criteria were revised to reduce unnecessary biopsies for benign nodules while maintaining an appropriate sensitivity for the detection of malignant tumors in small (1–2 cm) thyroid nodules. The goal of these recommendations is to provide the optimal scientific evidence and expert opinion consensus regarding US-based diagnosis and management of thyroid nodules. 
		                        		
		                        		
		                        		
		                        	
5.Hospital-based Influenza Morbidity and Mortality (HIMM) Surveillance for A/H7N9 Influenza Virus Infection in Returning Travelers
Joon Young SONG ; Ji Yun NOH ; Jacob LEE ; Heung Jeong WOO ; Jin Soo LEE ; Seong Heon WIE ; Young Keun KIM ; Hye Won JEONG ; Shin Woo KIM ; Sun Hee LEE ; Kyung Hwa PARK ; Seong Hui KANG ; Sae Yoon KEE ; Tae Hyong KIM ; Eun Ju CHOO ; Han Sol LEE ; Won Suk CHOI ; Hee Jin CHEONG ; Woo Joo KIM
Journal of Korean Medical Science 2018;33(7):e49-
		                        		
		                        			
		                        			Since 2013, the Hospital-based Influenza Morbidity and Mortality (HIMM) surveillance system began a H7N9 influenza surveillance scheme for returning travelers in addition to pre-existing emergency room (ER)-based influenza-like illness (ILI) surveillance and severe acute respiratory infection (SARI) surveillance. Although limited to eastern China, avian A/H7N9 influenza virus is considered to have the highest pandemic potential among currently circulating influenza viruses. During the study period between October 1st, 2013 and April 30th, 2016, 11 cases presented with ILI within seven days of travel return. These patients visited China, Hong Kong, or neighboring Southeast Asian countries, but none of them visited a livestock market. Seasonal influenza virus (54.5%, 6 among 11) was the most common cause of ILI among returning travelers, and avian A/H7N9 influenza virus was not detected during the study period.
		                        		
		                        		
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Emergency Service, Hospital
		                        			;
		                        		
		                        			Hong Kong
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Influenza A Virus, H7N9 Subtype
		                        			;
		                        		
		                        			Influenza, Human
		                        			;
		                        		
		                        			Livestock
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Orthomyxoviridae
		                        			;
		                        		
		                        			Pandemics
		                        			;
		                        		
		                        			Seasons
		                        			
		                        		
		                        	
6.Guideline on the prevention and control of seasonal influenza in healthcare setting.
Ji Hyeon BAEK ; Yu Bin SEO ; Won Suk CHOI ; Sae Yoon KEE ; Hye Won JEONG ; Hee Young LEE ; Byung Wook EUN ; Eun Ju CHOO ; Jacob LEE ; Sung Ran KIM ; Young Keun KIM ; Joon Young SONG ; Seong Heon WIE ; Jin Soo LEE ; Hee Jin CHEONG ; Woo Joo KIM
The Korean Journal of Internal Medicine 2014;29(2):265-280
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Antiviral Agents/*therapeutic use
		                        			;
		                        		
		                        			Cross Infection/diagnosis/*prevention & control/transmission/virology
		                        			;
		                        		
		                        			Evidence-Based Medicine/standards
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infection Control/*standards
		                        			;
		                        		
		                        			Infectious Disease Transmission, Patient-to-Professional/prevention & control
		                        			;
		                        		
		                        			Infectious Disease Transmission, Professional-to-Patient/prevention & control
		                        			;
		                        		
		                        			Influenza Vaccines/*administration & dosage
		                        			;
		                        		
		                        			Influenza, Human/diagnosis/*prevention & control/transmission/virology
		                        			;
		                        		
		                        			Occupational Health Services/*standards
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			*Seasons
		                        			;
		                        		
		                        			Vaccination/*standards
		                        			
		                        		
		                        	
7.Severe influenza treatment guideline.
Won Suk CHOI ; Ji Hyeon BAEK ; Yu Bin SEO ; Sae Yoon KEE ; Hye Won JEONG ; Hee Young LEE ; Byung Wook EUN ; Eun Ju CHOO ; Jacob LEE ; Young Keun KIM ; Joon Young SONG ; Seong Heon WIE ; Jin Soo LEE ; Hee Jin CHEONG ; Woo Joo KIM
The Korean Journal of Internal Medicine 2014;29(1):132-147
8.Guideline on the Prevention and Control of Seasonal Influenza in Healthcare Setting.
Ji Hyeon BAEK ; Yu Bin SEO ; Won Suk CHOI ; Sae Yoon KEE ; Hye Won JEONG ; Hee Young LEE ; Byung Wook EUN ; Eun Ju CHOO ; Jacob LEE ; Sung Ran KIM ; Young Keun KIM ; Joon Young SONG ; Seong Heon WIE ; Jin Soo LEE ; Hee Jin CHEONG ; Woo Joo KIM
Korean Journal of Medicine 2014;86(3):377-397
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Delivery of Health Care*
		                        			;
		                        		
		                        			Influenza, Human*
		                        			;
		                        		
		                        			Seasons*
		                        			
		                        		
		                        	
9.Evaluation of Transnasal Esophagogastroduodenoscopy as a Surveillance Endoscopy in a General Medical Checkup.
Yoon Jeong LEE ; Soon Young KO ; Sun Woong KIM ; Won Chan KANG ; Kanghoon LEE ; Jeong Hwan KIM ; Sun Young LEE ; Jong Hoon PARK ; Bong An PARK ; Jeong Rok LEE ; Sae Yoon KEE ; Hee Yeon SEO ; Hye Young KIM ; Jung Hwa LEE ; In Kyung SUNG
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2014;14(4):255-260
		                        		
		                        			
		                        			BACKGROUND/AIMS: Transnasal esophagogastroduodenoscopy (T-EGD) has been reported to be well tolerated and is known to reduce patient discomfort that occurs with conventional EGD (C-EGD) performed via an oral route. We aimed to evaluate factors that influence preferences for T-EGD as a surveillance EGD in a general medical checkup. MATERIALS AND METHODS: A total of 658 subjects (median age, 49 years; 45% men) underwent T-EGD procedures by 8 endoscopists using a 5.2-mm diameter endoscope. All examinees and endoscopists were asked to assess the T-EGD examinations using the post-endoscopy questionnaire. The post-endoscopy questionnaire included a 10-point visual analogue scale, which asked the patient to place a cross on the line according to examinee's or endoscopist's experience of the endoscopy procedure. Zero represented the worst experience and 10 the best experience. RESULTS: T-EGD was feasible in 96.6% of the subjects. Younger age (<35 years) and female sex were significant predictive factors for failure of the procedure. Older age (> or =35 years) or male examines preferred T-EGD as the modality for the next examination. The endoscopist's overall discomfort level was higher in the beginner group than in the expert group. CONCLUSIONS: The T-EGD may be better tolerated than C-EGD and offers a more comfortable surveillance endoscopic procedure to older (> or =35 years), male, or sedated C-EGD-experienced examinees in a general medical checkup. More experience with and education about T-EGD may help to improve the tolerance of the beginner group of endoscopists.
		                        		
		                        		
		                        		
		                        			Education
		                        			;
		                        		
		                        			Endoscopes
		                        			;
		                        		
		                        			Endoscopy*
		                        			;
		                        		
		                        			Endoscopy, Digestive System*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Personal Satisfaction
		                        			;
		                        		
		                        			Surveys and Questionnaires
		                        			
		                        		
		                        	
10.Severe Influenza Treatment Guideline.
Won Suk CHOI ; Ji Hyeon BAEK ; Yu Bin SEO ; Sae Yoon KEE ; Hye Won JEONG ; Hee Young LEE ; Byung Wook EUN ; Eun Ju CHOO ; Jacob LEE ; Young Keun KIM ; Joon Young SONG ; Seong Heon WIE ; Jin Soo LEE ; Hee Jin CHEONG ; Woo Joo KIM
Korean Journal of Medicine 2014;86(1):116-128
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Influenza, Human*
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail